首页> 外文会议>PSE Meeting on Natural Products in Cancer Prevention and Therapy >Euphorbia and Momordica metabolites for overcoming multidrug resistance
【24h】

Euphorbia and Momordica metabolites for overcoming multidrug resistance

机译:大戟和Momordica代谢物克服多药耐药性

获取原文

摘要

Multidrug resistance (MDR) is the major obstacle for cancer chemotherapy. MDR is a multifactorial phenomenon that can result from several mechanisms, including an increased drug efflux, due to overexpression of P-glycoprotein (P-gp) that transports anticancer drugs out of the cells. Thus, the role of this transporter has made it a therapeutic target and the development of P-gp modulators considered among the most realistic approaches for overcoming P-gp-mediated MDR. Many other strategies have been proposed. One of them is the identification of compounds that selectively kill multidrug resistant cells. In our search for MDR modulators from plants, the P-gp inhibition ability of a large number of compounds on resistant cancer cells was evaluated. These compounds, presented in this review, comprise mainly diterpenes, triterpenes and phenolic derivatives. The most relevant results were obtained from two sets of compounds: macrocyclic diterpenes with the jatrophane and lathyrane scaffold, and triterpenes of the cucurbitane-type isolated from Euphorbia species and Momordica balsamina L., respectively. Additionally, some of those macrocyclic diterpenes, and ent-abietane diterpenic lactones, also isolated from Euphorbia species, were found to be selectively toxic to drug-resistant phenotypes.
机译:多药耐药性(MDR)是癌症化疗的主要障碍。 MDR是一种多因素现象,其可以由几种机制导致,包括增加的药物流出,由于将抗癌药物从细胞中输送的p-糖蛋白(P-GP)的过度表达。因此,该转运蛋白的作用使其成为治疗靶标和P-GP调节剂的开发,认为是克服P-GP介导的MDR的最现实的方法。提出了许多其他策略。其中一个是鉴定选择性地杀死多药抗性细胞的化合物。在我们对来自植物的MDR调节剂的搜索中,评估大量化合物的P-GP抑制能力。在本综述中提出的这些化合物主要包含二萜,三萜和酚醛衍生物。从两组化合物中获得最相关的结果:分别从两组化合物:丙丙烷和甲炔支架的大环二萜,以及分别从大戟属物种和MOMORDICA BALAMINA L中分离的葫芦烷型的三萜。另外,发现一些宏环二萜以及来自大戟属物种中分离的百分之一的二萜内酯和eNT-上一萜烯内酯,对耐药表型有选择性地毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号